Biotechnology, Development, Industry and Methodologies

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

Harvard Business

MAY 10, 2016

Our experience with many global companies across industries and sectors has revealed a framework for pursuing growth through acquisition that lowers risks and helps beat the odds. For example, Gilead grew from a tiny startup developing H.I.V. This, in turn, leads bidders to overpay.

Company

Company Strategy Strategy Strategy&

The Promise and Challenge of Big Data for Pharma

Harvard Business

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Data

Data Pharmaceuticals Biotechnology Methodologies

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business

AUGUST 23, 2016

We also found that industry matters. Boards of companies operating in the consumer discretionary industry have a disproportionately high representation of Democrats, while boards operating in the industrials and energy and utilities industries skew more Republican. METHODOLOGY.

Telecommunications

Telecommunications Biotechnology Survey Healthcare

Management Consulting Connection

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

The Promise and Challenge of Big Data for Pharma

7 Charts Show How Political Affiliation Shapes U.S. Boards

Stay Connected